Botswana Health News API

{
    "totalArticles": 532,
    "articles": [
        {
            "id": "a61bb5e2ced41686267be3a8d743f809",
            "title": "Suicidal Thoughts Prompt New Warnings From Health Authorities For GLP-1 Drugs",
            "description": "The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric.",
            "content": "The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat diabetes, these drugs are now widely used for weight loss and have become household names.\nBut alongside headlines of dramatic tran... [4408 chars]",
            "url": "https://www.sciencealert.com/suicidal-thoughts-prompt-new-warnings-from-health-authorities-for-glp-1-drugs",
            "image": "https://www.sciencealert.com/images/2025/12/semaglutide_pen_header.jpg",
            "publishedAt": "2025-12-03T00:47:47Z",
            "lang": "en",
            "source": {
                "id": "76a2943c768c5c3be7d790e609b40403",
                "name": "ScienceAlert",
                "url": "https://www.sciencealert.com"
            }
        },
        {
            "id": "3faa8afa849bd9f03e90f176d126ab66",
            "title": "New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF",
            "description": "The Investor Relations website contains information about Biogen's business for stockholders, potential investors, and financial analysts.",
            "content": "TOKYO and CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) ... [25803 chars]",
            "url": "https://investors.biogen.com/news-releases/news-release-details/new-data-presented-clinical-trials-alzheimers-disease-ctad",
            "image": "https://investors.biogen.com/sites/g/files/knoqqb90876/files/favicon_0.ico",
            "publishedAt": "2025-12-02T21:41:45Z",
            "lang": "en",
            "source": {
                "id": "00f49970d1b56754e4a692c09e0404d4",
                "name": "Biogen",
                "url": "https://investors.biogen.com"
            }
        },
        {
            "id": "5abe243d41d2d8fd625422611236f0ee",
            "title": "Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors",
            "description": "An analysis, though based on self-reported data, hints that ischemic drivers of HF carry less clout than they did 35 years ago.",
            "content": "Over the last 35 years, the burden of heart failure (HF) has increased in the United States, though its prevalence by age has remained constant, according to registry data.\nResearchers also note a shift in underlying associated risk factors, with mor... [5274 chars]",
            "url": "https://www.tctmd.com/news/rising-hf-burden-us-potentially-related-changes-cardiometabolic-factors",
            "image": "https://d14d5nk8lue86f.cloudfront.net/s3fs-public/2025-12/Rising%20HF%20Burden%20in%20the%20US%20Potentially%20Related%20to%20Changes%20in%20Cardiometabolic%20Factors.jpg",
            "publishedAt": "2025-12-02T21:36:48Z",
            "lang": "en",
            "source": {
                "id": "6f1cf3918c9974e771cdda266d6941f0",
                "name": "TCTMD.com",
                "url": "https://www.tctmd.com"
            }
        }
    ]
}